Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 03, 2020 16:05 ET | Source: Organogenesis Holdings Inc.

Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September

CANTON, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization...
August 24, 2020 16:05 ET | Source: Organogenesis Holdings Inc.

Organogenesis Holdings Inc. Announces Management Change

CANTON, Mass., Aug. 24, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
August 10, 2020 16:05 ET | Source: Organogenesis Holdings Inc.

Organogenesis Holdings Inc. Reports Second Quarter and First Half 2020 Financial Results

CANTON, Mass., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
July 23, 2020 16:05 ET | Source: Organogenesis Holdings Inc.

Latest Advanced Wound Care Innovations and Research from Organogenesis to be Highlighted at SAWC Spring | WHS 2020 Virtual Meeting

CANTON, Mass., July 23, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of...
July 15, 2020 07:30 ET | Source: Organogenesis Holdings Inc.

Organogenesis Holdings Inc. Reports Preliminary Revenue Results for Second Quarter 2020

CANTON, Mass., July 15, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
June 29, 2020 07:30 ET | Source: Organogenesis Holdings Inc.

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2020 Financial Results on August 10, 2020

CANTON, Mass., June 29, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
May 11, 2020 16:05 ET | Source: Organogenesis Holdings Inc.

Organogenesis Holdings Inc. Reports First Quarter 2020 Financial Results

CANTON, Mass., May 11, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
April 13, 2020 16:05 ET | Source: Organogenesis Holdings Inc.

Organogenesis Announces Virtual Education Events for April

CANTON, Mass., April 13, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of...
April 08, 2020 16:05 ET | Source: Organogenesis Holdings Inc.

Organogenesis Holdings Inc. Reports Preliminary Revenue Results for First Quarter 2020

Withdraws Fiscal Year 2020 Revenue GuidanceAnnounces May 11, 2020 Earnings Conference Call CANTON, Mass., April 08, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading...
March 25, 2020 09:15 ET | Source: Organogenesis Holdings Inc.

Organogenesis To Sponsor March 26 Webinar, “Taking Control of the Wound Healing Environment,” Featuring Dr. Alisha Oropallo

CANTON, Mass., March 25, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization...